DE3856354D1 - Verfahren zur Identifizierung von Liganden für Retinsäurerezeptoren - Google Patents

Verfahren zur Identifizierung von Liganden für Retinsäurerezeptoren

Info

Publication number
DE3856354D1
DE3856354D1 DE3856354T DE3856354T DE3856354D1 DE 3856354 D1 DE3856354 D1 DE 3856354D1 DE 3856354 T DE3856354 T DE 3856354T DE 3856354 T DE3856354 T DE 3856354T DE 3856354 D1 DE3856354 D1 DE 3856354D1
Authority
DE
Germany
Prior art keywords
receptor
retinoic acid
novel
glucocorticoid
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3856354T
Other languages
English (en)
Other versions
DE3856354T2 (de
Inventor
Ronald Mark Evans
Vincent Giguere
Estelita Sebastian Ong
Prudimar Serrano Segui
Kazuhiko Umesono
Catherine Caroline Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salk Institute for Biological Studies
Original Assignee
Salk Institute for Biological Studies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26826487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3856354(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salk Institute for Biological Studies filed Critical Salk Institute for Biological Studies
Publication of DE3856354D1 publication Critical patent/DE3856354D1/de
Application granted granted Critical
Publication of DE3856354T2 publication Critical patent/DE3856354T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
DE3856354T 1987-12-02 1988-12-02 Verfahren zur Identifizierung von Liganden für Retinsäurerezeptoren Expired - Fee Related DE3856354T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12833187A 1987-12-02 1987-12-02
US07/276,536 US4981784A (en) 1987-12-02 1988-11-30 Retinoic acid receptor method

Publications (2)

Publication Number Publication Date
DE3856354D1 true DE3856354D1 (de) 1999-09-02
DE3856354T2 DE3856354T2 (de) 1999-12-16

Family

ID=26826487

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3854120T Expired - Fee Related DE3854120T2 (de) 1987-12-02 1988-12-02 Retinoesäure-Rezeptor-Komposition und Verfahren zur Ligand-Identifizierung.
DE3856354T Expired - Fee Related DE3856354T2 (de) 1987-12-02 1988-12-02 Verfahren zur Identifizierung von Liganden für Retinsäurerezeptoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE3854120T Expired - Fee Related DE3854120T2 (de) 1987-12-02 1988-12-02 Retinoesäure-Rezeptor-Komposition und Verfahren zur Ligand-Identifizierung.

Country Status (11)

Country Link
US (2) US4981784A (de)
EP (2) EP0540065B1 (de)
JP (3) JP3006716B2 (de)
KR (1) KR970009951B1 (de)
AT (2) ATE124721T1 (de)
AU (1) AU628312B2 (de)
DE (2) DE3854120T2 (de)
DK (1) DK136890A (de)
ES (1) ES2073408T3 (de)
IE (1) IE68590B1 (de)
WO (1) WO1989005355A1 (de)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855577T2 (de) * 1987-12-16 1997-04-17 Pasteur Institut Retinoesäurerezeptor und Derivate davon, beide Substanzen codierende DNS und die Verwendung der Proteine und der DNS
US5317090A (en) * 1987-12-16 1994-05-31 Institut Pasteur Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor
US5217867A (en) 1988-11-30 1993-06-08 The Salk Institute For Biological Studies Receptors: their identification, characterization, preparation and use
EP0451206A4 (en) * 1988-12-23 1992-07-22 The Salk Institute For Biological Studies Receptor transcription-repression activity compositions and methods
AU639699B2 (en) * 1988-12-23 1993-08-05 Salk Institute For Biological Studies, The Dominant negative members of the steroid/thyroid superfamily of receptors
ATE166360T1 (de) * 1989-03-17 1998-06-15 Salk Inst For Biological Studi Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon
US5260432A (en) * 1989-06-22 1993-11-09 Sloan-Kettering Institute For Cancer Research Human gamma retinoic acid receptor DNA
US5776502A (en) * 1989-07-18 1998-07-07 Oncogene Science, Inc. Methods of transcriptionally modulating gene expression
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
JPH05504254A (ja) * 1989-10-25 1993-07-08 ザ　ソーク　インスティテュート　フォア　バイオロジカル　スタディーズ レセプター感染アッセイ
EP0752477A3 (de) * 1990-01-16 1997-05-14 Baylor College Medicine Expressionsvektoren die Steroidrezeptoren produzieren, Steroidrezeptoren-Chimären, Screeningtests für Steroidrezeptoren und Verwendung der so hergestellten Rezeptoren und Rezeptor-Vektoren in klinischen Analysen
AU654270B2 (en) 1990-02-09 1994-11-03 Salk Institute For Biological Studies, The Retinoid receptor compositions and methods
US5861274A (en) * 1990-03-22 1999-01-19 The Salk Institute For Biological Studies Nucleic acids encoding peroxisome proliferator-activated receptor
CA2075192A1 (en) * 1990-03-22 1991-09-23 Anthony E. Oro Insect retinoid receptor compositions and methods
US5688691A (en) * 1990-03-22 1997-11-18 The Salk Institute For Biological Studies Insect retinoid-like receptor compositions and methods
US6440681B1 (en) 1990-04-03 2002-08-27 Merck & Co., Inc. Methods for identifying agonists and antagonists for human neuronal nicotinic acetylcholine receptors
US5369028A (en) * 1990-04-03 1994-11-29 The Salk Institute Biotechnology/Industrial Associates, Inc. DNA and mRNA encoding human neuronal nicotinic acetylcholine receptor compositions and cells transformed with same
US5599906A (en) * 1990-04-13 1997-02-04 Schering Corporation Protease assays
DK106490D0 (da) * 1990-04-30 1990-04-30 Novo Nordisk As Celle
IL97996A0 (en) * 1990-04-30 1992-06-21 Novo Nordisk As Hybrid cellular receptor
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
WO1992005286A1 (en) * 1990-09-24 1992-04-02 Roger Brent Screening assays
US5922596A (en) * 1990-12-10 1999-07-13 Bristol-Myers Squibb Co. Promoter of the retinoic acid receptor gene for directing gene expression
WO1992011365A1 (en) 1990-12-21 1992-07-09 The Rockefeller University Liver enriched transcription factor
AU679899B2 (en) * 1991-03-18 1997-07-17 Salk Institute For Biological Studies, The Response element compositions and assays employing same
US5834213A (en) * 1991-05-02 1998-11-10 Baylor College Of Medicine Screening system and assay for identifying compounds that regulate steroid and orphan receptors mediation of DNA transcription
WO1992022667A1 (en) * 1991-06-14 1992-12-23 University Of Medicine And Dentistry Of New Jersey Analogs of glycoprotein hormone receptors which bind choriogonadotrophins, leutrophins, and follitrophins and methods for preparing and using same
EP0600028B1 (de) * 1991-08-23 2001-11-07 The Salk Institute For Biological Studies Verwendung von selektiven liganden zur behandlung von hormonansprechenden krankheitzuständen
US5871909A (en) * 1991-08-30 1999-02-16 The Regents Of The University Of Michigan Human cellular retinoic acid binding protein I and II DNA and methods of use
DE69232537T2 (de) * 1991-09-17 2002-10-24 Salk Inst For Biolog Studies L Rezeptoren der steroid/thyroid superfamilie von rezeptoren
DE4138621A1 (de) * 1991-11-25 1993-06-17 Boehringer Ingelheim Int Verfahren zum screenen von substanzen mit modulierender wirkung auf einen rezeptorabhaengigen zellulaeren signaluebertragungsweg
WO1993012141A1 (en) * 1991-12-11 1993-06-24 Yale University Nucleotide and protein sequences of the serrate gene and methods based thereon
US6004924A (en) 1991-12-11 1999-12-21 Imperial Cancer Research Technology, Ltd. Protein sequences of serrate gene products
US5869282A (en) * 1991-12-11 1999-02-09 Imperial Cancer Research Technology, Ltd. Nucleotide and protein sequences of the serrate gene and methods based thereon
US5968989A (en) 1991-12-18 1999-10-19 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US7056954B2 (en) * 1991-12-18 2006-06-06 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
US6992108B1 (en) * 1991-12-18 2006-01-31 The Salk Institute For Biological Studies Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
EP0552612A3 (en) * 1992-01-22 1993-10-20 Hoffmann La Roche Methods for determining and isolating compounds which bind directly to nucleosolic proteins
US6989242B1 (en) 1992-02-26 2006-01-24 The General Hospital Coporation Car receptors and related molecules and methods
US5756448A (en) * 1992-02-26 1998-05-26 The General Hospital Corporation Constitute activator of retinoid (CAR) receptor polypeptides
CA2133325A1 (en) * 1992-04-21 1993-10-28 I. Charles Pathirana Non-steroid progesterone receptor agonist and antagonist compounds and methods
US5808139A (en) * 1992-04-21 1998-09-15 Ligand Pharmaceuticals Incorporated Non-steroid progesterone receptor agonist and antagonist and compounds and methods
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5962731A (en) * 1992-04-22 1999-10-05 Ligand Pharmaceuticals Incorporated Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
JPH08500963A (ja) * 1992-04-28 1996-02-06 ザ・リージェンツ・オブ・ザ・ユニヴァーシティー・オブ・ミシガン ヒューマンｃｒａｂｐ−▲ｉ▼及びｃｒａｂｐ−▲ｉｉ▼
WO1993023431A1 (en) 1992-05-14 1993-11-25 Baylor College Of Medicine Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
US6416998B1 (en) * 1992-09-02 2002-07-09 Baylor College Of Medicine Plasmid encoding a modified steroid hormone
JPH08506001A (ja) * 1992-10-01 1996-07-02 ザ ゼネラル ホスピタル コーポレーション 腫瘍サプレッサー遺伝子の機能検査
AU5165193A (en) * 1992-10-07 1994-04-26 Merck & Co., Inc. Human steroid hormone receptor neri
DK0680517T4 (da) * 1993-01-21 2005-05-02 Harvard College Fremgangsmåde og diagnostiske sæt til bestemmelse af en forbindelses toksicitet under anvendelse afstress-promotorer fra pattedyr
JP3824633B2 (ja) * 1993-02-12 2006-09-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・リランド・スタンフォード・ジュニアー・ユニバーシティ 標的遺伝子の調節的転写および他の生物学的結果
US6891021B2 (en) 1993-02-12 2005-05-10 Board Of Trustees Of The Leland Stanford Junior University Regulated apoptosis
WO1994020617A2 (en) * 1993-03-08 1994-09-15 The Salk Institute Biotechnology/Industrial Associates, Incorporated Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
SG54115A1 (en) * 1993-04-27 1998-11-16 Gerber Scient Products Inc Thermal printing apparatus with improved power supply
US6031149A (en) * 1993-05-18 2000-02-29 Institut National De La Sante Et De La Recherche Medicale Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
CA2140354A1 (en) * 1993-05-18 1994-11-24 Pierre Chambon Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
US5677336A (en) * 1993-10-21 1997-10-14 Ligand Pharmaceuticals Incorporated Non-steroid androgen receptor antagonist compounds and methods
US5506102A (en) * 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription
AU1091595A (en) * 1993-11-08 1995-05-29 Salk Institute Biotechnology/Industrial Associates, Inc., The Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
US5523209A (en) * 1994-03-14 1996-06-04 The Scripps Research Institute Methods for identifying inhibitors of integrin activation
JPH09511334A (ja) * 1994-03-30 1997-11-11 チバ−ガイギー アクチェンゲゼルシャフト Ｒｚｒ受容体ファミリーを用いるスクリーニング方法
EP0769052A2 (de) * 1994-07-01 1997-04-23 The Salk Institute For Biological Studies Säugertier peroxisompoliferator-aktivierte rezeptoren und verwendungen davon
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6309853B1 (en) 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US6048837A (en) * 1994-08-17 2000-04-11 The Rockefeller University OB polypeptides as modulators of body weight
US6124439A (en) * 1994-08-17 2000-09-26 The Rockefeller University OB polypeptide antibodies and method of making
US6124448A (en) * 1994-08-17 2000-09-26 The Rockfeller University Nucleic acid primers and probes for the mammalian OB gene
US5679518A (en) * 1994-10-27 1997-10-21 Merck & Co., Inc. Method for finding transcription activators of the NER steroid hormone receptor
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
US5702914A (en) * 1994-12-21 1997-12-30 The Salk Institute For Biological Studies Use of reporter genes for retinoid receptor screening assays having novel retinoid-associated response elements
US5932699A (en) * 1995-01-13 1999-08-03 The General Hospital Corporation Retinoid X receptor-interacting polypeptides
US6391847B1 (en) 1995-01-17 2002-05-21 The Salk Institute For Biological Studies Method, polypeptides, nucleotide sequence of XOR-6, a vitamin D-like receptor from xenopus
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
WO1996034091A1 (en) * 1995-04-28 1996-10-31 Wisconsin Alumni Research Foundation Method for measuring hormones in biological samples
US6485967B1 (en) 1995-06-07 2002-11-26 Merck & Co., Inc. Human neuronal nicotinic acetylcholine receptor α6 and β3 nucleic acid
US5726050A (en) * 1995-06-20 1998-03-10 Massachusetts Institute Of Technology Z-DNA binding protein and applications
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US6326140B1 (en) * 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US6489441B1 (en) 1995-09-01 2002-12-03 The Salk Institute For Biological Studies Transcriptional co-repressor that interacts with nuclear hormone receptors
DK0792292T4 (da) * 1995-09-08 2009-07-20 Karobio Ab Orphan-receptor
EP0788353A1 (de) 1995-09-18 1997-08-13 Ligand Pharmaceuticals, Inc. Ppar gamma antagonisten zur behandlung der fettleibigkeit
EP0873295B1 (de) * 1995-10-06 2003-04-02 Ligand Pharmaceuticals, Inc. Dimer-selektive rxr modulatoren und verfahren zu ihrer verwendung
KR19990064155A (ko) 1995-10-10 1999-07-26 더블류. 하링, 지. 보이롤 수용체 매개된 트랜스활성화에 의해 식물에서 유전자 발현을조절하기 위한 화학적 리간드로서의유충 호르몬 또는 이의효능제
US20030044914A1 (en) * 1996-01-16 2003-03-06 The Salk Institute For Biological Studies Methods employing XOR-6, a vitamin D-like receptor from xenopus
US6723531B2 (en) 1996-04-05 2004-04-20 The Salk Institute For Biological Studies Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
US5919667A (en) * 1996-06-20 1999-07-06 The Salk Institute For Biological Studies Modular assembly retroviral vectors and uses thereof
US6017924A (en) 1996-06-27 2000-01-25 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
AU5729098A (en) * 1996-12-24 1998-07-17 Zymogenetics Inc. Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
US6268165B1 (en) 1997-03-19 2001-07-31 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
EP0977892A1 (de) 1997-04-24 2000-02-09 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methoden und zusammensetzungen zur regulation der expresssion von matrix-metalloproteinase genen
US6528271B1 (en) * 1997-06-05 2003-03-04 Duke University Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
US7541151B2 (en) 1997-06-05 2009-06-02 Duke University Single-cell biosensor for the measurement of GPCR ligands in a test sample
US6300488B1 (en) 1997-07-10 2001-10-09 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
US6222015B1 (en) 1997-09-08 2001-04-24 Merck & Co., Inc. Estrogen receptor
US6521814B1 (en) 1997-12-22 2003-02-18 Institut National De La Santa Et De La Recherche Medicale Use of ligands for treatment of diseases responsive to retinoids
US6348348B1 (en) * 1998-04-07 2002-02-19 The Carnegie Institution Of Washington Human hairless gene and protein
US6333318B1 (en) * 1998-05-14 2001-12-25 The Salk Institute For Biological Studies Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
AU4676999A (en) 1998-06-12 1999-12-30 Ligand Pharmaceuticals, Inc. Treatment of anti-estrogen resistant breast cancer using rxr modulators
AR021484A1 (es) 1998-09-10 2002-07-24 Pioneer Hi Bred Int Nuevos receptores de ecdisona y metodos de uso de los mismos
CA2343320A1 (en) * 1998-09-18 2000-03-30 The Rockefeller University Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof
DE19855013C2 (de) 1998-11-20 2001-09-13 Schering Ag Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element
US6773911B1 (en) * 1998-11-23 2004-08-10 Amgen Canada Inc. Apoptosis-inducing factor
US7056656B1 (en) 1999-01-25 2006-06-06 University Of Medicine And Dentistry Of New Jersey Tat-derived oligourea and its method of production and use in high affinity and specific binding HIV-1 TAR RNA
US20020132223A1 (en) * 1999-03-26 2002-09-19 City Of Hope Methods for modulating activity of the FXR nuclear receptor
US6548739B2 (en) * 1999-06-18 2003-04-15 City Of Hope Method for activating peroxisome proliferator activated receptor-γ
US6586189B2 (en) 1999-06-18 2003-07-01 City Of Hope Screening method for PPAR-γ ligands
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
JP2003508397A (ja) 1999-08-27 2003-03-04 リガンド・ファーマシューティカルズ・インコーポレイテッド アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物
AU5701399A (en) * 1999-09-01 2001-03-26 Bristol-Myers Squibb Company In vitro transcription systems and uses
US6593493B1 (en) 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
WO2001021215A1 (en) * 1999-09-22 2001-03-29 Ortho-Mcneil Pharmaceutical, Inc. Cell based assay
AU7736300A (en) 1999-09-30 2001-04-30 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
US7057015B1 (en) * 1999-10-20 2006-06-06 The Salk Institute For Biological Studies Hormone receptor functional dimers and methods of their use
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
WO2001038564A2 (en) 1999-11-26 2001-05-31 Mcgill University Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
BRPI0107715B8 (pt) 2000-01-21 2021-05-25 Novartis Ag produto farmacêutico compreendendo um inibidor de dipeptidilpeptidase-iv e metformina, bem como usos do dito produto farmacêutico e do inibidor de dipeptidilpeptidase-iv
EP1259537A4 (de) * 2000-02-24 2004-05-12 Salk Inst For Biological Studi Genexpressionssystem basierend auf chimären rezeptoren
US20040033600A1 (en) * 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
US20020022599A1 (en) * 2000-03-24 2002-02-21 Synold Timothy W. Methods of modulating drug clearance mechanisms by altering SXR activity
WO2002000618A2 (en) * 2000-06-28 2002-01-03 University Technology Corporation Progesterone receptor-regulated gene expression and methods related thereto
IL153833A0 (en) * 2000-07-18 2003-07-31 Novartis Ag Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
US7011972B2 (en) 2000-07-18 2006-03-14 The Scripps Research Institute Fusion polypeptide comprising two ligand binding domains
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
JP2004533212A (ja) * 2000-10-24 2004-11-04 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 植物における遺伝子発現のコントロール
US7163800B2 (en) * 2000-11-03 2007-01-16 Molecular Devices Corporation Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US7018812B2 (en) * 2000-11-03 2006-03-28 Duke University Modified G-protein coupled receptors
US20050136431A1 (en) * 2000-11-03 2005-06-23 Oakley Robert H. Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
US20040053839A1 (en) * 2000-12-21 2004-03-18 Andrea Leblanc Method of protecting cells against apoptosis and assays to identify agents which modulate apoptosis
DK1456346T3 (da) 2001-02-20 2012-05-29 Intrexon Corp Nyt inducerbart genekspressionssystem baseret på ecdysonreceptor/invertebrat-retinoid-x-receptor
ES2424812T3 (es) 2001-02-20 2013-10-08 Intrexon Corporation Receptores X retinoides quiméricos y su uso en un sistema inducible de expresión génica basado en receptores de ecdisona novedoso
AU2002306550B2 (en) 2001-02-20 2007-10-25 Intrexon Corporation Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
EP1534738B1 (de) 2001-02-20 2012-06-20 Intrexon Corporation Neue substitutionsmutantenrezeptoren und ihre verwendung in einem induzierbaren genexpressionsystem auf grundlage eines nukleären rezeptors
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
US20040102367A1 (en) * 2001-02-23 2004-05-27 Gage Fred H Gene expression system based on chimeric receptors
US7214690B2 (en) * 2001-02-23 2007-05-08 Ligand Pharmaceuticals Incorporated Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods
US20040143015A1 (en) * 2001-03-12 2004-07-22 Villhauer Edwin Bernard Combination of organic compounds
WO2002072528A1 (en) * 2001-03-14 2002-09-19 Eli Lilly And Company Fluorinated trienes and their use as rxr modulators
US20030003517A1 (en) * 2001-03-22 2003-01-02 Klein Elliott S. Methods of detecting dissociated nuclear hormone receptor ligands
CA2441808A1 (en) * 2001-03-23 2002-10-03 Syngenta Participations Ag Insect nuclear receptor genes and uses thereof
AU2002307393A1 (en) * 2001-04-20 2002-11-05 The Salk Institute For Biological Studies Inducible expression of transfected genes
US20110313230A1 (en) 2001-05-11 2011-12-22 Terrance Grant Johns Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US7589180B2 (en) 2001-05-11 2009-09-15 Abbott Laboratories Inc. Specific binding proteins and uses thereof
WO2002095405A1 (en) * 2001-05-21 2002-11-28 The Regents Of The University Of California Membrane-resident steroid receptors and methods of use thereof
EP1414450A1 (de) * 2001-07-20 2004-05-06 Eli Lilly And Company (pyridinyl und pyrimidyl)triensäurederivate als retinoid x rezeptor modulatoren
EP1288303A1 (de) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Induzierbare Expressionssysteme unter Verwendung von PPAR Transkriptionsaktivatoren
AU2002333682A1 (en) * 2001-08-02 2003-02-17 Gencell S.A. Inducible expression systems employing ppar transcriptional activators
US7919269B2 (en) * 2001-09-26 2011-04-05 Intrexon Corporation Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
MXPA04002810A (es) * 2001-09-26 2005-06-06 Rheogene Holdings Inc Acidos nucleicos receptores de ecdisona de saltarilla, polipeptidos, y sus usos.
WO2003027639A2 (en) * 2001-09-28 2003-04-03 Hager Gordon L Glucocorticoid receptor nuclear translocation domain
US20030212138A1 (en) * 2002-01-14 2003-11-13 Pharmacia Corporation Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
US20030220374A1 (en) * 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20030182669A1 (en) * 2002-03-19 2003-09-25 Rockman Howard A. Phosphoinositide 3-kinase mediated inhibition of GPCRs
US8673589B2 (en) 2002-05-29 2014-03-18 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
WO2003101189A1 (en) * 2002-05-29 2003-12-11 Regeneron Pharmaceuticals, Inc. Inducible eukaryotic expression system
US7290215B2 (en) * 2002-06-03 2007-10-30 Microsoft Corporation Dynamic wizard interface system and method
US7375093B2 (en) 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
EP1388352A1 (de) 2002-08-08 2004-02-11 Laboratoires Fournier S.A. Verwendung eines ppar-alpha-Agonisten zur Behandlung von Patienten, die an mit ppar-gamma-Agonisten-Behandlung assozierter Fettleibigkeit leiden
EP2371955A1 (de) 2002-09-26 2011-10-05 K.U. Leuven Research & Development Integrase-Cofaktor
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7304162B2 (en) * 2003-02-21 2007-12-04 Intrexon Corporation Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
EP1641555B1 (de) 2003-04-30 2020-12-02 Nexus Biosystems, Inc. Hochdichte lagerung und eine analyseplattform bereitstellende mehrlochplatte
BRPI0413820A (pt) * 2003-08-22 2006-10-24 Ligand Pharm Inc derivados de 6-cicloamino-2-quinolinona como compostos moduladores de receptor de androgênio
US7767792B2 (en) 2004-02-20 2010-08-03 Ludwig Institute For Cancer Research Ltd. Antibodies to EGF receptor epitope peptides
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
US7935510B2 (en) * 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
AU2005247943A1 (en) 2004-05-23 2005-12-08 Gerard M. Housey Theramutein modulators
WO2006007854A1 (en) * 2004-07-23 2006-01-26 Rheoscience A/S Gus3 neuropeptides for regulating hypothalamic function
US7544838B2 (en) 2005-01-21 2009-06-09 City Of Hope Ligands for estrogen related receptors and methods for synthesis of said ligands
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
BRPI0609191B8 (pt) * 2005-06-17 2021-05-25 Ligand Pharm Inc métodos e compostos moduladores de receptor de androgênio
ES2445180T5 (es) 2005-09-14 2022-02-01 Takeda Pharmaceuticals Co Administración de inhibidores de dipeptidil peptidasa
CN103789389B (zh) * 2005-11-23 2017-01-04 杰勒德·M·豪斯 鉴定、合成、优化和表征蛋白调节剂的化合物和方法
US20080107597A1 (en) * 2006-01-12 2008-05-08 Anaptys Biosciences, Inc. Isolation of antibodies that cross-react and neutralize rankl originating from multiple species
US8076517B2 (en) 2007-05-29 2011-12-13 Intrexon Corporation Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
EP2185730A4 (de) 2007-08-23 2010-10-27 Intrexon Corp Verfahren und zusammensetzungen zur krankheitsdiagnose
NZ584848A (en) 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
EP2207874B1 (de) 2007-10-08 2014-12-03 Intrexon Corporation Technisch manipulierte dendritische zellen und verwendungen zur krebsbehandlung
US8354446B2 (en) 2007-12-21 2013-01-15 Ligand Pharmaceuticals Incorporated Selective androgen receptor modulators (SARMs) and uses thereof
US8536354B2 (en) 2008-03-14 2013-09-17 Intrexon Corporation Steroidal ligands and their use in gene switch modulation
US20110076232A1 (en) 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
WO2011041293A1 (en) 2009-09-30 2011-04-07 Takeda Pharmaceutical Company Limited Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors
DK2531501T3 (en) 2010-02-03 2014-02-24 Takeda Pharmaceutical APOPTOSESIGNALREGULERENDE KINASE 1 inhibitors
JP2013527753A (ja) 2010-03-23 2013-07-04 イントレキソン コーポレーション 治療タンパク質を条件的に発現するベクター、該ベクターを含む宿主細胞およびそれらの使用
JP6189754B2 (ja) 2011-03-04 2017-08-30 イントレキソン コーポレーション タンパク質を条件的に発現するベクター
US9127024B2 (en) 2013-03-15 2015-09-08 Intrexon Corporation Boron-containing diacylhydrazines
US10441567B2 (en) 2014-01-17 2019-10-15 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels
AU2015317862A1 (en) 2014-09-17 2017-04-06 Intrexon Corporation Boron-containing diacylhydrazine compounds
UY37343A (es) 2016-07-25 2018-02-28 Intrexon Corp Control del fenotipo en plantas
CA3042706A1 (en) 2016-11-09 2018-05-17 Intrexon Corporation Frataxin expression constructs
EP3612210A4 (de) 2017-04-19 2021-01-27 Board Of Regents, The University Of Texas System Manipulierte antigenrezeptoren exprimierende immunzellen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US5274077A (en) * 1987-12-02 1993-12-28 The Salk Institute For Biological Studies Retinoic acid receptor composition
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition

Also Published As

Publication number Publication date
AU628312B2 (en) 1992-09-17
DK136890D0 (da) 1990-06-01
EP0325849B1 (de) 1995-07-05
ATE124721T1 (de) 1995-07-15
DK136890A (da) 1990-06-01
WO1989005355A1 (en) 1989-06-15
EP0325849A3 (de) 1991-10-16
KR900700601A (ko) 1990-08-16
IE68590B1 (en) 1996-06-26
ATE182685T1 (de) 1999-08-15
EP0540065B1 (de) 1999-07-28
AU2818889A (en) 1989-07-05
JP3006716B2 (ja) 2000-02-07
JPH10279599A (ja) 1998-10-20
DE3854120D1 (de) 1995-08-10
IE883621L (en) 1989-06-02
JPH10295385A (ja) 1998-11-10
EP0325849A2 (de) 1989-08-02
ES2073408T3 (es) 1995-08-16
EP0540065A1 (de) 1993-05-05
KR970009951B1 (ko) 1997-06-19
US5599904A (en) 1997-02-04
JPH03503597A (ja) 1991-08-15
US4981784A (en) 1991-01-01
DE3854120T2 (de) 1996-01-11
DE3856354T2 (de) 1999-12-16

Similar Documents

Publication Publication Date Title
DE3856354T2 (de) Verfahren zur Identifizierung von Liganden für Retinsäurerezeptoren
Simon et al. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t (17; 22)(q22; q13. 1) in dermatofibrosarcoma protuberans (DP)
Kent et al. A male-specific role for SOX9 in vertebrate sex determination
Corps et al. Receptors for epidermal growth factor and insulin-like growth factor-I on preimplantation trophoderm of the pig
EP0648228B8 (de) Bnp antikörper und immunologischer nachweis der ihn benutzt
DE3851967D1 (de) Verfahren zur Bestimmung von Antikörpern.
DE69323765D1 (de) Säugetier-rezeptoren für interleukin 10 (il-10)
ATE139784T1 (de) Hybrid-rezeptoren, diese kodierende nukleinsäure, ihre herstellung und ihre verwendung zur bestimmung von liganden sowie deren antagonisten oder agonisten
DE69029197T2 (de) Gamma-retinoinsäure-rezeptor
ES2061273T3 (es) Ensayo para proteinas glicadas de la sangre.
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DE69030579D1 (de) Verfahren zur herstellung von fusionsproteinen
WO2000001817A3 (en) Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
KR950700328A (ko) 레티노산 응답요소의 구성 활성화인자 수용체 및 관련 분자와 방법(carreceptors and related molecules and methods)
Linsley et al. Direct linkage of EGF to its receptor: characterization and biological relevance
ATE366120T1 (de) Hocheffizientes gewebespezifisches system zur bereitstellung von verbindungen unter verwendung eines streptavidin-protein a fusionsproteins
DE19728991A1 (de) Rezeptorbindungsassay, für den Rezeptorbindungsassay geeigneter rekombinanter Fusionsrezeptor, Vektor zu dessen Herstellung sowie Reagenziensatz für die Durchführung des Rezeptorbindungsassays
Gerdes et al. Signal-mediated sorting to the regulated pathway of protein secretion
WO2002008723A2 (de) Verfahren zur selektiven bestimmung von blockierenden autoantikörpern gegen den tsh-rezeptor
Evans et al. Chimeric steroid hormone superfamily receptor proteins
JP4147305B2 (ja) ヒト成体由来の膵臓内分泌細胞に分化可能な細胞に特有な表面抗原とこの表面抗原による細胞分離法
JPH01501896A (ja) 多色ウエスタンブロット
ATE8411T1 (de) Verfahren zur spezifischen abspaltung von proteinsequenzen aus proteinen.
Scopsi et al. Bodian's silver impregnation of endocrine cells: A tentative explanation to the staining mechanism
SEQUENCING PREGANCY SPECIFIC PROTEINS APPLICATIONS

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee